Skip to main content
John Beigel, MD, Internal Medicine, Bethesda, MD

John Herber Beigel MD

Critical Care Medicine, Infectious Disease


Physician

Join to View Full Profile
  • 10 Center DrBethesda, MD 20892

  • Phone+1 301-451-9881

Dr. Beigel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Critical Care Medicine (Internal Medicine), 2000 - 2004
  • Mass General Brigham/Massachusetts General Hospital/Brigham and Women's Hospital
    Mass General Brigham/Massachusetts General Hospital/Brigham and Women's HospitalFellowship, Infectious Disease, 2001 - 2003
  • University of Cincinnati Medical Center/College of Medicine
    University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 1995 - 1998
  • The University of Toledo College of Medicine
    The University of Toledo College of MedicineClass of 1995

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2003 - 2026
  • DC State Medical License
    DC State Medical License 2003 - 2013
  • OH State Medical License
    OH State Medical License 1996 - 2007
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Critical Care Medicine
    American Board of Internal Medicine Critical Care Medicine
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Safety, Tolerability, and Pharmacokinetics of Radavirsen (AVI‐7100), an Antisense Oligonucleotide Targeting Influenza a M1/M2 Translation  
    Richard T Davey, John H Beigel, British Journal of Clinical Pharmacology

Press Mentions

  • COVID-19 Vaccines: From Nasal Drops to a Redesign, What 2023 Could Have in Store
    COVID-19 Vaccines: From Nasal Drops to a Redesign, What 2023 Could Have in StoreJanuary 9th, 2023
  • Monkeypox Appears to Recede, but Risks and Uncertainties Linger
    Monkeypox Appears to Recede, but Risks and Uncertainties LingerSeptember 26th, 2022
  • FDA to Stretch Monkeypox Vaccine Supply via Intradermal Injection
    FDA to Stretch Monkeypox Vaccine Supply via Intradermal InjectionAugust 12th, 2022
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: